Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. A | 20 | 1 | 3 | 1 | €148.06 | €201.64 | 36.185% |
| XOMA Corp. | 4 | 0 | 1 | 0 | €22.80 | €68.78 | 201.664% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 1 | 0 | €1.63 | €4.39 | 169.240% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| X4 Pharmaceuticals, Inc. | 4 | 0 | 1 | 0 | €1.09 | €2.76 | 153.003% |
| WAVE Life Sciences Ltd | 8 | 0 | 1 | 0 | €4.44 | €9.10 | 104.973% |
| Vivoryon Therapeutics N.V. | 1 | 0 | 0 | 0 | €0.79 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €345.00 | - | - |
| Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.81 | - | - |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €69.44 | €140.00 | 101.613% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.81 | - | - |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 5 | 0 | €371.40 | €382.71 | 3.044% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €41.80 | - | - |
| Verastem Inc. | 9 | 0 | 0 | 0 | €8.60 | €27.03 | 214.314% |
| Vanda Pharmaceuticals | 4 | 0 | 2 | 0 | €4.32 | €5.00 | 15.741% |
| Valneva SE | 2 | 0 | 0 | 0 | €3.51 | €7.00 | 99.544% |
| United Therapeutics | 15 | 0 | 0 | 0 | €220.00 | €289.92 | 31.782% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €41.40 | €82.93 | 100.317% |
| UCB S.A. | 2 | 0 | 0 | 0 | €124.95 | - | - |
| Trinity Biotech ADR | 23 | 0 | 2 | 0 | €0.41 | - | - |
| TG Therapeutics Inc. | 20 | 4 | 3 | 0 | €12.58 | €27.00 | 114.527% |
| Teva Pharmaceutical Industries Ltd ADR | 11 | 0 | 0 | 0 | €12.95 | €13.50 | 4.247% |
| Taro Pharmaceutical Industries Ltd | 7 | 0 | 1 | 0 | €39.00 | - | - |
| Syros Pharmaceuticals Inc. | 5 | 1 | 3 | 1 | €4.70 | €12.80 | 172.372% |
| Sutro Biopharma Inc | 18 | 0 | 4 | 0 | €3.16 | €11.05 | 249.633% |